146 related articles for article (PubMed ID: 18420922)
1. Cell signaling. Wnt moves beyond the canon.
Bowerman B
Science; 2008 Apr; 320(5874):327-8. PubMed ID: 18420922
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors.
Witze ES; Litman ES; Argast GM; Moon RT; Ahn NG
Science; 2008 Apr; 320(5874):365-9. PubMed ID: 18420933
[TBL] [Abstract][Full Text] [Related]
3. Wnt5A activates the calpain-mediated cleavage of filamin A.
O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
[TBL] [Abstract][Full Text] [Related]
4. Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.
O'Connell MP; Weeraratna AT
Pigment Cell Melanoma Res; 2009 Dec; 22(6):724-39. PubMed ID: 19708915
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a directs polarized calcium gradients by recruiting cortical endoplasmic reticulum to the cell trailing edge.
Witze ES; Connacher MK; Houel S; Schwartz MP; Morphew MK; Reid L; Sacks DB; Anseth KS; Ahn NG
Dev Cell; 2013 Sep; 26(6):645-57. PubMed ID: 24091015
[TBL] [Abstract][Full Text] [Related]
6. Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior.
Wang W; Runkle KB; Terkowski SM; Ekaireb RI; Witze ES
J Biol Chem; 2015 Jun; 290(25):15707-15716. PubMed ID: 25944911
[TBL] [Abstract][Full Text] [Related]
7. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.
Wang Q; Symes AJ; Kane CA; Freeman A; Nariculam J; Munson P; Thrasivoulou C; Masters JR; Ahmed A
PLoS One; 2010 May; 5(5):e10456. PubMed ID: 20454608
[TBL] [Abstract][Full Text] [Related]
8. Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension.
Ye Z; Zhang C; Tu T; Sun M; Liu D; Lu D; Feng J; Yang D; Liu F; Yan X
Nat Commun; 2013; 4():2803. PubMed ID: 24335906
[TBL] [Abstract][Full Text] [Related]
9. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
10. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.
Babayeva S; Zilber Y; Torban E
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F549-60. PubMed ID: 20534871
[TBL] [Abstract][Full Text] [Related]
11. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
12. Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.
Hansen C; Howlin J; Tengholm A; Dyachok O; Vogel WF; Nairn AC; Greengard P; Andersson T
J Biol Chem; 2009 Oct; 284(40):27533-43. PubMed ID: 19651774
[TBL] [Abstract][Full Text] [Related]
13. Assaying Wnt5A-mediated invasion in melanoma cells.
O'Connell MP; French AD; Leotlela PD; Weeraratna AT
Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260
[TBL] [Abstract][Full Text] [Related]
14. Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.
Miller SG; Hoh M; Ebmeier CC; Tay JW; Ahn NG
Mol Biol Cell; 2024 Mar; 35(3):ar31. PubMed ID: 38117590
[TBL] [Abstract][Full Text] [Related]
15. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
16. A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis.
Webster MR; Weeraratna AT
Sci Signal; 2013 Mar; 6(268):pe11. PubMed ID: 23532332
[TBL] [Abstract][Full Text] [Related]
17. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
[TBL] [Abstract][Full Text] [Related]
18. Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.
Dejmek J; Säfholm A; Kamp Nielsen C; Andersson T; Leandersson K
Mol Cell Biol; 2006 Aug; 26(16):6024-36. PubMed ID: 16880514
[TBL] [Abstract][Full Text] [Related]
19. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
Ekström EJ; Sherwood V; Andersson T
PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
[TBL] [Abstract][Full Text] [Related]
20. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
Anastas JN; Kulikauskas RM; Tamir T; Rizos H; Long GV; von Euw EM; Yang PT; Chen HW; Haydu L; Toroni RA; Lucero OM; Chien AJ; Moon RT
J Clin Invest; 2014 Jul; 124(7):2877-90. PubMed ID: 24865425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
